改良急诊流程对急性脑梗死溶栓患者抢救疗效的影响

目的观察急诊流程改良对急性脑梗死溶栓患者抢救疗效的影响。方法医院收治急性脑梗死溶栓患者68例,根据不同急救流程分为对照组和观察组,每组34例。对照组根据常规急诊流程对急性脑梗死溶栓患者进行抢救,观察组在常规急诊流程上进行改良对急性脑梗死溶栓患者进行抢救。比较2组抢救时间、抢救成功率、抢救费用,治疗后血清炎性因子(TNF-α、IL-6)水平、神经功能NIHSS表评分,患者总满意度。结果观察组抢救成功率为97. 06%,高于对照组的76. 47%(P <0. 05);观察组抢救时间短于对照组,抢救费用少于对照组(P <0. 01);治疗后,观察组NIHSS评分、血清TNF-α和IL-6水平均低于对照组(P <0. 01);观察组患者总满意度为97. 06%,高于对照组的76. 47%(P <0. 05)。结论急诊流程改良在抢救急性脑梗死溶栓患者的过程可有效提高抢救效率,不仅缩短患者的抢救时间,还减少相关并发症和治疗费用。

61例急性乙醇中毒昏迷期患者诊断抢救疗效的回顾性分析

目的总结急性乙醇中毒昏迷期患者的诊断抢救体会,减少漏诊、误诊、误治,做到正确诊断和合理治疗,提高抢救成功率。方法对2006年1月~2009年11月我院急诊科收治的急性乙醇中毒昏迷期患者61例的诊断及采取不同抢救措施疗效的回顾性分析。结果急性乙醇中毒昏迷期患者61例,通过积极处理其中病情好转无不良反应者42例。残存不同后遗症者12例,死亡7例。结论急性乙醇中毒昏迷期患者因病史的缺乏导致诊断较困难,同时易掩盖并发症导致漏诊、误诊、误治。患者抢救成功与否,与急诊科医师的临床抢救经验、抢救方法,以及病程长短、有无合并症密切相关。

观察微量注射泵胰岛素输注在糖尿病酮症酸中毒抢救中的疗效

探讨应用微型静脉泵治疗治疗糖尿病酮症的效果。方法 选取了本院2022年1月到2022年12月间,共有20名糖尿病酮症酸中毒的病人,根据信封法,将他们分为10人和10人两组,对照组使用静脉滴注,观察组使用微量注射泵进行胰岛素的输入。对治疗前后患者的生活质量评分,治疗前后总的胰岛素用量,血糖达标时间,尿酮阴性时间,治疗前后的总有效率,低血糖发生率等进行了对比分析。结果 在改善临床症状的同时,观察组的总的胰岛素用量,血糖达标的时间,以及尿酮为阴性的时间,均较对照组的总的生命质量得分有所提高,总的有效率也有所提高,P<0.05,患者的低血糖率均显著降低, P<0.05;结论 探讨应用微量注射泵胰岛素治疗 DM酮症,探讨其临床应用价值显示其作用突出。

优化急诊护理流程对急诊胸痛患者抢救的疗效观察

探讨对急性胸痛患者抢救时应用优化急诊护理流程的临床效果。方法:将急诊收治的120例胸痛患者作为本次研究对象,按照随机分组法将其分为参照组(采用常规护理流程)与试验组(采用优化急诊护理流程),每组各60例,所有患者均于2020.2-2020.10被我院收治,对比两组护理后抢救效果。结果:试验组在住院时间、急诊停留时间、分诊评估时间以及急救时间对比中均短于参照组,组间对比具有差异性,P<0.05。结论:将优化急诊护理流程实施于急诊胸痛患者,可有效缩短其住院时间、急诊停留时间、分诊评估时间以及急救时间,进一步提高临床救治效率,值得推广。

Salvage liver transplantation in the treatment of hepatocellular carcinoma:A Meta-analysis

AIM:To evaluate survival and recurrence after salvage liver transplantation(SLT) for the treatment of hepatocellular carcinoma(HCC) compared with primary liver transplantation(PLT) using a meta-analysis.METHODS:Literature on SLT versus PLT for the treatment of HCC published between 1966 and July 2011 was retrieved.A meta-analysis was conducted to estimate pooled survival and disease-free rates.A fixed or random-effect model was established to collect the data.RESULTS:The differences in overall survival and disease-free survival rates at 1-year,3-year and 5-year survival rates were not statistically significant between SLT group and PLT group(P > 0.05).After stratifying the various studies by donor source and Milan criteria,we found that:(1) Living donor liver transplantation recipients had significantly higher 1-year survival rate,lower 3-year and 5-year survival rates compared with deceased-donor liver transplantation(DDLT) recipients.And in DDLT recipients they had better 1-year and 5-year disease-free survival rate in SLT group;and(2) No difference was seen in 1-year,3-year and 5-year survival rates between two groups who beyond Milan criteria at the time of liver transplantation.CONCLUSION:SLT can be effectively performed for patients with recurrence or deterioration of liver function after hepatectomy for HCC.It does not increase the perioperative mortality and has a similar long-term survival rates compared to PLT.